分子亚型-话题@MedSci

#分子亚型#

20篇内容 | 1444人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2236018, encodeId=1a35223601863, content=<a href='/topic/show?id=774c1248491' target=_blank style='color:#2F92EE;'>#NAFLD#</a> <a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=STM：陆军军医大学柴进等利用综合多组学分析确定了中国人群中不同的NAFLD分子亚型！, objectType=article, longId=850511, objectId=964885051172, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401030/1730265935847_8538692.jpg, objectUrl=/article/show_article.do?id=964885051172, replyNumber=0, likeNumber=35, createdTime=2024-11-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=964885051172, moduleTitle=STM：陆军军医大学柴进等利用综合多组学分析确定了中国人群中不同的NAFLD分子亚型！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=964885051172)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1339945, encodeId=82c713399452e, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=J Hepatol：新型的儿童肝癌分子亚型已被科学家识别到！, objectType=article, longId=728110, objectId=5f93e2811028, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f93e2811028, replyNumber=0, likeNumber=106, createdTime=2022-05-30, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f93e2811028, moduleTitle=J Hepatol：新型的儿童肝癌分子亚型已被科学家识别到！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f93e2811028)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339944, encodeId=939f1339944c4, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=Gastric Cancer: D1/D2和CRITICS研究事后探索可手术不同分子亚型胃癌对新辅助化疗的应答和预后, objectType=article, longId=299222, objectId=3b272992229b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b272992229b, replyNumber=0, likeNumber=87, createdTime=2022-02-21, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b272992229b, moduleTitle=Gastric Cancer: D1/D2和CRITICS研究事后探索可手术不同分子亚型胃癌对新辅助化疗的应答和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b272992229b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339943, encodeId=b07013399433d, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=European Radiology：如何应用CT预测胃癌的EMT分子亚型？, objectType=article, longId=295738, objectId=61cc295e3827, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61cc295e3827, replyNumber=0, likeNumber=88, createdTime=2022-02-17, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61cc295e3827, moduleTitle=European Radiology：如何应用CT预测胃癌的EMT分子亚型？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61cc295e3827)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339942, encodeId=e02e133994284, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=European Radiology：通过结构化报告系统，对胶质瘤分子亚型和风险分层的可重复成像预测, objectType=article, longId=293032, objectId=5b8c29303285, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b8c29303285, replyNumber=0, likeNumber=96, createdTime=2021-12-30, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b8c29303285, moduleTitle=European Radiology：通过结构化报告系统，对胶质瘤分子亚型和风险分层的可重复成像预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b8c29303285)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339941, encodeId=09a6133994149, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=European Radiology：如何无创获得弥漫性胶质瘤的分子亚型？影像学有话说！, objectType=article, longId=292800, objectId=f4b72928005e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4b72928005e, replyNumber=0, likeNumber=81, createdTime=2021-12-28, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4b72928005e, moduleTitle=European Radiology：如何无创获得弥漫性胶质瘤的分子亚型？影像学有话说！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4b72928005e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339940, encodeId=7b9c13399407d, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=Eur Urol：不同分子亚型的尿路上皮癌对新辅助化疗的差异反应分析, objectType=article, longId=221754, objectId=a389221e54ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a389221e54ed, replyNumber=0, likeNumber=104, createdTime=2021-12-10, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a389221e54ed, moduleTitle=Eur Urol：不同分子亚型的尿路上皮癌对新辅助化疗的差异反应分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a389221e54ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339939, encodeId=097c13399391a, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=JAMA Oncol：非转移去势抵抗性前列腺癌的分子亚型与Apalutamide治疗结果差异的关系 , objectType=article, longId=213257, objectId=9d5921325e93, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d5921325e93, replyNumber=0, likeNumber=72, createdTime=2021-06-27, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d5921325e93, moduleTitle=JAMA Oncol：非转移去势抵抗性前列腺癌的分子亚型与Apalutamide治疗结果差异的关系 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d5921325e93)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339938, encodeId=cf081339938bb, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=Eur Urol：前列腺特异性膜抗原和氟尿嘧啶转运体基因与原发性前列腺癌的不同临床特征和分子亚型有关 , objectType=article, longId=210652, objectId=f4f92106522f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4f92106522f, replyNumber=0, likeNumber=100, createdTime=2021-05-01, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4f92106522f, moduleTitle=Eur Urol：前列腺特异性膜抗原和氟尿嘧啶转运体基因与原发性前列腺癌的不同临床特征和分子亚型有关 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4f92106522f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339937, encodeId=28c9133993e0b, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=Eur Urol：深度学习预测肌层浸润膀胱癌分子亚型 , objectType=article, longId=194759, objectId=f085194e597f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f085194e597f, replyNumber=0, likeNumber=86, createdTime=2020-05-28, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f085194e597f, moduleTitle=Eur Urol：深度学习预测肌层浸润膀胱癌分子亚型 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f085194e597f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339936, encodeId=2c491339936a3, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=Eur Urol：分子亚型和免疫浸润对肌层浸润性膀胱癌新辅助Pembrolizumab治疗的病理响应和结果影响, objectType=article, longId=190995, objectId=3a86190995c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a86190995c8, replyNumber=0, likeNumber=50, createdTime=2020-03-29, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a86190995c8, moduleTitle=Eur Urol：分子亚型和免疫浸润对肌层浸润性膀胱癌新辅助Pembrolizumab治疗的病理响应和结果影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a86190995c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339935, encodeId=638f13399353b, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=ARCH PATHOL LAB MED：利用免疫组化和原位杂交鉴定乳腺Paget病的分子亚型, objectType=article, longId=159575, objectId=23621595e571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23621595e571, replyNumber=0, likeNumber=81, createdTime=2019-02-08, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23621595e571, moduleTitle=ARCH PATHOL LAB MED：利用免疫组化和原位杂交鉴定乳腺Paget病的分子亚型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23621595e571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339934, encodeId=8fbf1339934c3, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=Brit J Cancer：II/III期结肠癌患者边侧性、分子亚型及治疗响应, objectType=article, longId=126567, objectId=c2d012656e30, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2d012656e30, replyNumber=0, likeNumber=65, createdTime=2018-01-17, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2d012656e30, moduleTitle=Brit J Cancer：II/III期结肠癌患者边侧性、分子亚型及治疗响应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2d012656e30)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339933, encodeId=c74d133993374, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=CLIN CANCER RES：肺大细胞神经内分泌癌分子亚型可预测化疗反应, objectType=article, longId=125962, objectId=24d1125962cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24d1125962cc, replyNumber=0, likeNumber=71, createdTime=2018-01-10, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24d1125962cc, moduleTitle=CLIN CANCER RES：肺大细胞神经内分泌癌分子亚型可预测化疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24d1125962cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339932, encodeId=603f133993261, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=CLIN CANCER RES：根据外阴癌遗传特征定义具有预后意义的分子亚型, objectType=article, longId=120328, objectId=e82b120328d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e82b120328d7, replyNumber=0, likeNumber=124, createdTime=2017-11-18, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e82b120328d7, moduleTitle=CLIN CANCER RES：根据外阴癌遗传特征定义具有预后意义的分子亚型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e82b120328d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339931, encodeId=dd6513399313d, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=Ann Oncol：都是NSCLC，不同分子亚型CTC表现不同, objectType=article, longId=105723, objectId=68da105e234b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68da105e234b, replyNumber=0, likeNumber=68, createdTime=2017-07-18, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68da105e234b, moduleTitle=Ann Oncol：都是NSCLC，不同分子亚型CTC表现不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68da105e234b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339930, encodeId=94ff133993005, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=Cancer Treat Rev：如何实现结直肠癌分子亚型与临床病理表型的互通转化？, objectType=article, longId=100605, objectId=9a81100605d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a81100605d5, replyNumber=0, likeNumber=60, createdTime=2017-06-04, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a81100605d5, moduleTitle=Cancer Treat Rev：如何实现结直肠癌分子亚型与临床病理表型的互通转化？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a81100605d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339929, encodeId=45ed1339929a7, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=SCI REP：分子亚型对转移性乳腺癌患者的影响, objectType=article, longId=93737, objectId=3b9293e37e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b9293e37e7, replyNumber=0, likeNumber=83, createdTime=2017-03-29, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b9293e37e7, moduleTitle=SCI REP：分子亚型对转移性乳腺癌患者的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b9293e37e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339928, encodeId=667c133992881, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=Radiology：乳腺癌Luminal B分子亚型在MR图像显示出病灶增强, objectType=article, longId=43201, objectId=f53d43201a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f53d43201a1, replyNumber=0, likeNumber=69, createdTime=2014-11-28, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f53d43201a1, moduleTitle=Radiology：乳腺癌Luminal B分子亚型在MR图像显示出病灶增强, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f53d43201a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339927, encodeId=0e2b133992e17, content=<a href='/topic/show?id=0ec031565c3' target=_blank style='color:#2F92EE;'>#分子亚型#</a>, objectTitle=Gastroenterology:PI3K抑制剂和5-氟尿嘧啶有不同疗效的胃癌分子亚型, objectType=article, longId=23917, objectId=0ae62391e12, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ae62391e12, replyNumber=0, likeNumber=66, createdTime=2013-09-07, rootId=0, userName=HinsMax, userId=910c2500152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ae62391e12, moduleTitle=Gastroenterology:PI3K抑制剂和5-氟尿嘧啶有不同疗效的胃癌分子亚型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ae62391e12)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

分子亚型

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#NAFLD# #分子亚型#

STM：陆军军医大学柴进等利用综合多组学分析确定了中国人群中不同的NAFLD分子亚型！

2024-11-09发表于上海

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

J Hepatol：新型的儿童肝癌分子亚型已被科学家识别到！

2022-05-30

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

Gastric Cancer: D1/D2和CRITICS研究事后探索可手术不同分子亚型胃癌对新辅助化疗的应答和预后

2022-02-21

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

European Radiology：如何应用CT预测胃癌的EMT分子亚型？

2022-02-17

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

European Radiology：通过结构化报告系统，对胶质瘤分子亚型和风险分层的可重复成像预测

2021-12-30

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

European Radiology：如何无创获得弥漫性胶质瘤的分子亚型？影像学有话说！

2021-12-28

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

Eur Urol：不同分子亚型的尿路上皮癌对新辅助化疗的差异反应分析

2021-12-10

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

JAMA Oncol：非转移去势抵抗性前列腺癌的分子亚型与Apalutamide治疗结果差异的关系

2021-06-27

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

Eur Urol：前列腺特异性膜抗原和氟尿嘧啶转运体基因与原发性前列腺癌的不同临床特征和分子亚型有关

2021-05-01

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

Eur Urol：深度学习预测肌层浸润膀胱癌分子亚型

2020-05-28

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

Eur Urol：分子亚型和免疫浸润对肌层浸润性膀胱癌新辅助Pembrolizumab治疗的病理响应和结果影响

2020-03-29

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

ARCH PATHOL LAB MED：利用免疫组化和原位杂交鉴定乳腺Paget病的分子亚型

2019-02-08

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

Brit J Cancer：II/III期结肠癌患者边侧性、分子亚型及治疗响应

2018-01-17

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

CLIN CANCER RES：肺大细胞神经内分泌癌分子亚型可预测化疗反应

2018-01-10

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

CLIN CANCER RES：根据外阴癌遗传特征定义具有预后意义的分子亚型

2017-11-18

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

Ann Oncol：都是NSCLC，不同分子亚型CTC表现不同

2017-07-18

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

Cancer Treat Rev：如何实现结直肠癌分子亚型与临床病理表型的互通转化？

2017-06-04

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

SCI REP：分子亚型对转移性乳腺癌患者的影响

2017-03-29

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

Radiology：乳腺癌Luminal B分子亚型在MR图像显示出病灶增强

2014-11-28

HinsMax (审核中...)

前往app查看评论内容

#分子亚型#

Gastroenterology:PI3K抑制剂和5-氟尿嘧啶有不同疗效的胃癌分子亚型

2013-09-07

科室
- - 订阅+
  - 更多科室
工具
服务